• Return to Headlines

Insmed Inc: The Winning Streak Continues (INSM)

By Shiri Gupta

Insmed Inc (NASDAQ:INSM) traded today at a new 52-week high of $29.52. Approximately 9.1 million shares have changed hands today, as compared to an average 30-day volume of 353,000 shares.

Insmed, Inc. is a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need battling serious orphan lung diseases.

Insmed Inc (NASDAQ:INSM) is currently priced 12.7% above its average consensus analyst price target of $24.71. Insmed Inc shares have support at the 200-day moving average (MA) of $17.50 and additional support at the 50-day MA of $12.50.

Over the past year, Insmed Inc has traded in a range of $9.02 to $29.52 and is now at $28.32, 214% above that low. The 200-day and 50-day moving averages have moved 1.65% lower and 0.79% lower over the past week, respectively.

SmarTrend recommended that its subscribers protect gains by selling shares of Insmed Inc on August 2nd, 2017 by issuing a Downtrend alert when the shares were trading at $15.57. Since that call, shares of Insmed Inc have fallen 21.0%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows insmed inc

Ticker(s): INSM